BlackRock Fund Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $34.4M | Buy |
1,347,553
+150,501
| +13% | +$3.84M | 0.01% | 1892 |
|
|
2016
Q3 | $43.3M | Buy |
1,197,052
+68,974
| +6% | +$2.5M | 0.01% | 1680 |
|
|
2016
Q2 | $38.3M | Buy |
1,128,078
+57,968
| +5% | +$1.97M | 0.01% | 1672 |
|
|
2016
Q1 | $28.2M | Buy |
1,070,110
+149,193
| +16% | +$3.94M | 0.01% | 1783 |
|
|
2015
Q4 | $44.9M | Sell |
920,917
-60,434
| -6% | -$2.95M | 0.01% | 1551 |
|
|
2015
Q3 | $24.4M | Buy |
981,351
+40,479
| +4% | +$1.01M | 0.01% | 1864 |
|
|
2015
Q2 | $29.8M | Buy |
940,872
+116,140
| +14% | +$3.67M | 0.01% | 1865 |
|
|
2015
Q1 | $31.4M | Buy |
824,732
+33,383
| +4% | +$1.27M | 0.01% | 1808 |
|
|
2014
Q4 | $30.8M | Buy |
791,349
+435,934
| +123% | +$17M | 0.01% | 1801 |
|
|
2014
Q3 | $10.7M | Sell |
355,415
-7,013
| -2% | -$212K | ﹤0.01% | 2304 |
|
|
2014
Q2 | $12.3M | Buy |
362,428
+162,329
| +81% | +$5.51M | ﹤0.01% | 2294 |
|
|
2014
Q1 | $6.9M | Buy |
200,099
+25,145
| +14% | +$867K | ﹤0.01% | 2620 |
|
|
2013
Q4 | $6.93M | Buy |
+174,954
| New | +$6.93M | ﹤0.01% | 2596 |
|